Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

BPC-157

Body Protection Compound-157, PL-14736, Pentadecapeptide BPC 157

A synthetic pentadecapeptide derived from human gastric juice that promotes tissue healing, angiogenesis, and cytoprotection across various organs.

Quick Stats
Studies 196
Trials 1
Formula C62H98N16O22
Clear All
Utility 3
pubmed 2001

Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents.

Stancic-Rokotov. D D; Sikiric. P P; Seiwerth. S S; Slobodnjak. Z Z; Aralica. J J; Aralica. G G; Pero...

In rats, damaging the lungs first makes alcohol‑induced stomach ulcers worse, but giving anti‑ulcer drugs—including the peptide BPC‑157—protects the stomach. BPC‑157 worked whether given before or after the alcohol, and repeated dosing boosted its effect. This suggests BPC‑157 could help guard the gut against ulcer‑type damage, though it’s an animal study and human dosing isn’t known.

Utility 3
pubmed 2001

Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.

Stancic-Rokotov. D D; Slobodnjak. Z Z; Aralica. J J; Aralica. G G; Perovic. D D; Staresinic. M M; Gj...

In rats, the ulcer‑healing peptide BPC‑157 (and some common anti‑ulcer drugs) reduced damage to the lungs caused by a strong acid spill. The protection was strongest when the peptide was given both before the injury and again later, and higher doses worked best. These results suggest BPC‑157 might help protect lung tissue, but the work is still in animals and the exact human dose isn’t known.

Utility 3
pubmed 2001

Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats.

Prkacin. I I; Aralica. G G; Perovic. D D; Separovic. J J; Gjurasin. M M; Lovric-Bencic. M M; Stancic...

In rats that drank alcohol for months, giving the peptide BPC‑157 (or the drugs ranitidine and propranolol) either before, during, or after the drinking stopped stomach ulcers from forming and even healed existing damage. The peptide also helped protect the liver and lower portal pressure, while the other drugs mainly helped the stomach.

Utility 3
pubmed 2001

Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat.

Sikiric. P P; Seiwerth. S S; Aralica. G G; Perovic. D D; Staresinic. M M; Anic. T T; Gjurasin. M M;...

In rats, the peptide BPC‑157 helped heal and keep healed severe colon ulcers caused by a chemical called cysteamine. It worked as well as, or better than, common ulcer medicines and stopped the ulcers from coming back after treatment stopped.

Utility 3
pubmed 2000

Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157.

Sikiric. P P; Separovic. J J; Buljat. G G; Anic. T T; Stancic-Rokotov. D D; Mikus. D D; Duplancic. B...

In rats, blocking dopamine signals with two drugs caused big stomach ulcers, but giving the peptide BPC‑157 (a short chain of 15 amino acids) stopped those ulcers from forming, even when the dopamine blockage was very strong. This shows BPC‑157 can protect the stomach lining under severe chemical stress.

Utility 3
pubmed 2000

The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants.

Sikiric. P P; Separovic. J J; Buljat. G G; Anic. T T; Stancic-Rokotov. D D; Mikus. D D; Marovic. A A...

In rats, the stomach peptide BPC‑157 acted like an antidepressant, cutting the time the animals stayed immobile in forced‑swim tests. It worked as well as standard drugs such as imipramine, but showed effects faster—within 4‑6 days of daily dosing—while the traditional drug needed longer exposure. The benefit persisted even when the stress model got tougher, where the usual drugs lost some effectiveness.

Utility 3
pubmed 1999

A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine.

Sikiric. P P; Marovic. A A; Matoz. W W; Anic. T T; Buljat. G G; Mikus. D D; Stancic-Rokotov. D D; Se...

In mice that were given chemicals that cause Parkinson‑like brain damage, a tiny peptide called BPC‑157 dramatically reduced the movement problems, tremors and catalepsy, and even rescued mice that would otherwise die. The peptide also protected the stomach lining from the same chemicals. It worked whether it was given before or after the toxin, and only tiny amounts (nanograms to micrograms per kilogram) were needed.

Utility 3
pubmed 1999

Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice.

Petek. M M; Sikiric. P P; Anic. T T; Buljat. G G; Separovic. J J; Stancic-Rokotov. D D; Seiwerth. S...

In rats and mice, a chemical that mimics diabetes (alloxan) damages the stomach lining, but giving the peptide BPC‑157 at very tiny doses (either 10 µg/kg or 10 ng/kg) at the same time cuts down the damage. The protection works in both species and at both dose levels.

Utility 3
pubmed 1999

The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation.

Sikiric. P P; Separovic. J J; Anic. T T; Buljat. G G; Mikus. D D; Seiwerth. S S; Grabarevic. Z Z; St...

In a rat study, the peptide BPC‑157 boosted the growth of new blood vessels and increased the amount of fresh healing tissue (granulation) more than common stomach medicines. While other drugs like H2‑blockers and omeprazole also helped make new vessels, they did not improve the amount of healing tissue. This suggests BPC‑157 has a unique ability to speed up tissue repair.

Utility 3
pubmed Jul 30, 1997

The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.

Sikirić. P P; Seiwerth. S S; Grabarević. Z Z; Rucman. R R; Petek. M M; Jagić. V V;...

In rats, the peptide BPC‑157 helped prevent stomach ulcers and could blunt blood‑pressure spikes caused by a drug that blocks nitric‑oxide (NO) production. It also made its own NO‑like effect that wasn’t stopped by the NO blocker, but when mixed with the NO‑precursor L‑arginine the two seemed to cancel each other out.

Utility 3
pubmed 1997

BPC 157's effect on healing.

Seiwerth. S S; Sikiric. P P; Grabarevic. Z Z; Zoricic. I I; Hanzevacki. M M; Ljubanovic. D D; Coric....

In rats, the peptide BPC‑157 helped wounds heal faster by boosting the formation of new tissue, collagen, and blood vessels, and it made the repaired tissue stronger. These benefits were seen whether the peptide was taken by mouth or applied directly to the wound.

Utility 3
pubmed 1997

Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats.

Sikiric. P P; Seiwerth. S S; Grabarevic. Z Z; Rucman. R R; Petek. M M; Jagic. V V; Turkovic. B B; Ro...

In rats, a tiny peptide called BPC‑157 helped protect the stomach and intestines from damage caused by common painkillers like ibuprofen and aspirin, and it also reduced joint inflammation in a model of arthritis. The peptide was effective when given just before the drug, at the same time, or as a daily dose over weeks to months.

Utility 3
pubmed 1997

Evidence for direct cellular protective effect of PL-10 substances (synthesized parts of body protection compound, BPC) and their specificity to gastric mucosal cells.

Bódis. B B; Karádi. O O; Németh. P P; Dohoczky. C C; Kolega. M M; Mózsik. G G

In a lab test, tiny pieces of the BPC-157 molecule (called PL-10 substances) were safe for cells and helped protect rat stomach lining cells from damage caused by alcohol, but they didn’t help a different type of cancer cell. The protection worked at very low concentrations (as low as 50 ng/ml).

Utility 3
pubmed 1997

Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.

Sikirić. P P; Mazul. B B; Seiwerth. S S; Grabarević. Z Z; Rucman. R R; Petek. M M; Jagi&...

In rats, the peptide BPC‑157 shields the stomach and liver from damage caused by acute stress. Its protective power depends on the nervous system: blocking certain alpha‑adrenergic or dopamine receptors wipes out the benefit, while beta‑blockers only interfere when the peptide is taken by mouth. Adding adrenaline (which hits both alpha and beta receptors) together with a dopamine‑activating drug (bromocriptine) further cuts down stress‑induced lesions.

Utility 3
pubmed 1993

A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC.

Sikirić. P P; Petek. M M; Rucman. R R; Seiwerth. S S; Grabarević. Z Z; Rotkvić. I...

BPC‑157 is a tiny peptide found in stomach juice that appears to protect many organs from damage. In animal studies it works at very low doses (micrograms or nanograms per kilogram) when given by injection, orally, or directly to the gut, and it shows benefits even when given after injury. No obvious side effects or toxicity were reported, but the exact way it works is still unclear.

Utility 3
pubmed 1993

Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin.

Sikiric. P P; Seiwerth. S S; Grabarevic. Z Z; Rucman. R R; Petek. M M; Rotkvic. I I; Turkovic. B B;...

In a rat study, the 15‑amino‑acid peptide BPC‑157 protected the liver from damage caused by blocked bile ducts, extreme stress, or a toxic chemical, and it worked better than some drugs usually used for liver problems. The protection was seen whether the peptide was taken by mouth or injected, and the usual blood tests for liver health matched the tissue results. The authors say this could mean BPC‑157 might be useful for human liver disease, but more research is needed.

Utility 3
pubmed 2017

Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats.

Vitaic. S S; Stupnisek. M M; Drmic. D D; Bauk. L L; Kokot. A A; Klicek. R R; Vcev. A A; Luetic. K K;...

In rats, the peptide BPC‑157 (a stable 15‑amino‑acid fragment) prevented the drop in pressure of the lower esophageal and pyloric sphincters that normally follows high‑dose NSAID use. When BPC‑157 was given right after the NSAIDs, the sphincters stayed functional, whereas untreated rats showed a rapid and lasting loss of pressure.